Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H4N2 |
| Molecular Weight | 80.088 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CN=NC=C1
InChI
InChIKey=PBMFSQRYOILNGV-UHFFFAOYSA-N
InChI=1S/C4H4N2/c1-2-4-6-5-3-1/h1-4H
| Molecular Formula | C4H4N2 |
| Molecular Weight | 80.088 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| CoMFA based de novo design of pyridazine analogs as PTP1B inhibitors. | 2007-07 |
|
| Silver(I) sulfate coordination polymers with 4,4'-bipyridazine and pyridazino[4,5-d]pyridazine. | 2007-06 |
|
| Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry. | 2007-06 |
|
| 13C-1H HSQC experiment of probe molecules aligned in thermotropic liquid crystals: sensitivity and resolution enhancement in the indirect dimension. | 2007-04 |
|
| Luminescent hydrido-carbonyl clusters of rhenium containing bridging 1,2-diazine ligands. | 2006-12-25 |
|
| A self-assembled hexadecanuclear 4 x[2 x 2] Mn(II)16 square grid from a pyridazine bis(hydrazone) ligand: synthesis, structure and magnetism. | 2006-12-21 |
|
| Metal-organic frameworks exhibiting strong anion-pi interactions. | 2006-12-14 |
|
| Estimation of local density augmentation and hydrogen bonding between pyridazine and water under sub- and supercritical conditions using UV-vis spectroscopy. | 2006-11 |
|
| Donor-acceptor-donor-type liquid crystal with a pyridazine core. | 2006-10-12 |
|
| A computational study on pi and sigma modes of metal ion binding to heteroaromatics (CH)(5-m)X(m) and (CH)(6-m)X(m) (X = N and P): contrasting preferences between nitrogen- and phosphorous-substituted rings. | 2006-08-24 |
|
| Triphenylene analogues with B2N2C2 cores: synthesis, structure, redox behavior, and photophysical properties. | 2006-08-23 |
|
| Use of 4-bromo pyridazine 3,6-dione for building 3-amino pyridazine libraries. | 2006-08 |
|
| 3-Benzidino-6(4-chlorophenyl) pyridazine blocks delayed rectifier and transient outward potassium current in acutely isolated rat hippocampal pyramidal neurons. | 2006-07-10 |
|
| Pulsed-field ionization electron spectroscopy and ab initio calculations of copper-diazine complexes. | 2006-07-07 |
|
| Copper complexes with heterocyclic sulfonamides: synthesis, spectroscopic characterization, microbiological and SOD-like activities: crystal structure of [Cu(sulfisoxazole)2(H2O)4] . 2H2O. | 2006-07 |
|
| A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties. | 2006-06-29 |
|
| Kinetics and mechanism of the reactions of Pd(II) complexes with azoles and diazines. Crystal structure of [Pd(bpma)(H2O)](ClO4)2.2H2O. | 2006-06-28 |
|
| The in vivo metabolism of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine in rats. | 2006-05-24 |
|
| Anion-pi interactions as controlling elements in self-assembly reactions of Ag(I) complexes with pi-acidic aromatic rings. | 2006-05-03 |
|
| Determination of natural abundance 15N-1H and 13C-1H dipolar couplings of molecules in a strongly orienting media using two-dimensional inverse experiments. | 2006-05 |
|
| A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety. | 2006-04-20 |
|
| Vibrational spectroscopy of the pyridazine cation in the ground state. | 2006-03-02 |
|
| Cadmium nitrate coordination polymers with substituted pyridazino[4,5-d]pyridazines. | 2006-02 |
|
| Pyrrolopyridazine MEK inhibitors. | 2006-02 |
|
| Synthetic approaches to polypyridyl bridging ligands with proximal multidentate binding sites. | 2006-01-06 |
|
| Monoclinic and triclinic concomitant polymorphs of di-mu-pyridazine-1kappa(2)N:2kappa(2)N'-bis[(saccharinato)silver(I)]. | 2006-01 |
|
| Current status of anti-picornavirus therapies. | 2006 |
|
| Hydrogen bond directed synthesis of pyridazine and naphthyridine containing macrocycles. | 2005-12-14 |
|
| Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitors. | 2005-12-01 |
|
| Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents. | 2005-12 |
|
| Interplay between intra- and interligand charge transfer with variation of the axial N-heterocyclic ligand in osmium(II) pyridylpyrazolate complexes: extensive color tuning by phosphorescent solvatochromism. | 2005-10-21 |
|
| Fully dimensional ab initio description of the structure and energetics of azabenzene-argon complexes. | 2005-10-15 |
|
| Cyclization reactions of acylium and thioacylium ions with isocyanates and isothiocyanates: gas phase synthesis of 3,4-dihydro-2,4-dioxo-2H-1,3,5-oxadiazinium ions. | 2005-10 |
|
| A new pyridazine series of GABAA alpha5 ligands. | 2005-09-22 |
|
| Vibrational spectra and potential energy distributions for 4,5-dichloro-3-hydroxypyridazine by density functional theory and normal coordinate calculations. | 2005-09 |
|
| Dye-sensitized photooxygenation of furanosyl furans: synthesis of a new pyridazine C-nucleoside. | 2005-08-05 |
|
| Total synthesis of ningalin D. | 2005-08-03 |
|
| Dimetallic complexes of a structurally versatile pyridazine-containing Schiff-base macrocyclic ligand with pendant pyridine arms. | 2005-07-21 |
|
| Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase. | 2005-05-02 |
|
| Validation of the neuroinflammation cycle as a drug discovery target using integrative chemical biology and lead compound development with an Alzheimer's disease-related mouse model. | 2005-04 |
|
| Synthesis of 3-alkylthio-6-allylthiopyridazine derivatives and their antihepatocarcinoma activity. | 2005-04 |
|
| Docking of 6-chloropyridazin-3-yl derivatives active on nicotinic acetylcholine receptors into molluscan acetylcholine binding protein (AChBP). | 2005-04 |
|
| Neutral Cu4N12 and Ag4N12 metallacycles with a para-cyclophane framework assembled from copper(I) and silver(I) pyrazolates and pyridazine. | 2005-03-28 |
|
| 3,6-bis(2'-pyridyl)pyridazine (L) and its deprotonated form (L - H+)- as ligands for {(acac)2Ru(n+)} or {(bpy)2Ru(m+)}: investigation of mixed valency in [{(acac)2Ru}2(mu-L - H+)]0 and [{(bpy)2Ru}2(mu-L - H+)]4+ by spectroelectrochemistry and EPR. | 2005-02-21 |
|
| Synthesis and herbicidal activity of novel heterocyclic protoporphyrinogen oxidase inhibitors. | 2004-12 |
|
| 5'-(2-phosphoryl-1,4-dioxobutane) as a product of 5'-oxidation of deoxyribose in DNA: elimination as trans-1,4-dioxo-2-butene and approaches to analysis. | 2004-11 |
|
| Pyridazine derivatives and related compounds. Part 13: Synthesis and antimicrobial activity of some pyridazino[3',4':3,4]pyrazolo[5,1-c]-1,2,4-triazines. | 2004-10-04 |
|
| Zonal ablation of the olfactory sensory neuroepithelium of the mouse: effects on odorant detection. | 2004-10 |
|
| The influence of water on the rates of 1,3-dipolar cycloaddition reactions: trigger points for exponential rate increases in water-organic solvent mixtures. Water-super versus water-normal dipolarophiles. | 2004-09-29 |
|
| N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy. | 2004-09-09 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:54:34 GMT 2025
by
admin
on
Mon Mar 31 20:54:34 GMT 2025
|
| Record UNII |
449GLA0653
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
449GLA0653
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
30954
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
206-025-5
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
90792
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
PYRIDAZINE
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
289-80-5
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
DTXSID7059777
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
9259
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | |||
|
m9350
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
C062482
Created by
admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |